Feb 05, 2020
Kodiak Sciences Announces Upcoming Presentation of Additional KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2020 Meeting
Jan 13, 2020
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
Dec 19, 2019
Kodiak Sciences Appoints Taiyin Yang, Ph.D., to Board of Directors
Dec 02, 2019
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Nov 19, 2019
Autonomous AI diagnostics launch in retail health clinics
Nov 06, 2019
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.
Nov 05, 2019
Primary Care Doctors Identify Patients with Eye Disease Using Artificial Intelligence
Oct 23, 2019
Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
Oct 11, 2019
Kodiak Sciences to Host R&D Day on October 14 in San Francisco to Highlight Recent Clinical Progress and Development Planning for KSI-301
Oct 11, 2019
Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration
Oct 08, 2019
Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
Oct 07, 2019
Kodiak Sciences Announces Upcoming Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at American Academy of Ophthalmology 2019 Annual Meeting
Oct 03, 2019
Allergan to Showcase Late-Stage Data in Age-Related Macular Degeneration and Glaucoma at American Academy of Ophthalmology Annual Meeting
Sep 18, 2019
Anterior Uveitis Treatment Market Size Worth $418.23 Million By 2026: Grand View Research, Inc.
Sep 15, 2019
Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting
Aug 14, 2019
Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights
Aug 05, 2019
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients
May 14, 2019
LORATI Successfully Develops Effective Treatment for Diabetic Macular Edema Using Eye Drops
May 13, 2019
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy
Apr 25, 2019
Kodiak Sciences Announces Presentations at ARVO 2019 Annual Meeting